Cargando…
Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.
Circulating serum factors have been said to abrogate the effects of immune response in cancer, i.e. "blocking" and "antigenic inhibition". The aim of this investigation was to isolate such specific factors in a purified and native state. F(ab)2 fragments isolated from hypernephro...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1975
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025021/ https://www.ncbi.nlm.nih.gov/pubmed/1220760 |
_version_ | 1782136679495106560 |
---|---|
author | Langvad, E. Hydén, H. Wolf, H. Kroeigaard, N. |
author_facet | Langvad, E. Hydén, H. Wolf, H. Kroeigaard, N. |
author_sort | Langvad, E. |
collection | PubMed |
description | Circulating serum factors have been said to abrogate the effects of immune response in cancer, i.e. "blocking" and "antigenic inhibition". The aim of this investigation was to isolate such specific factors in a purified and native state. F(ab)2 fragments isolated from hypernephroma were insolubilized on the surfaces of an extracorporeal perfusion chamber which was inserted into the circulation by means of an arterio-venous shunt. As a result, 3 proteins not present in normal serum were isolated and eluted for further study. In immunoelectrophoresis the 3 proteins were specifically precipitated by heterolgous (rabbit) antihypernephroma serum but not by anti-serum directed against normal serum components. Moreover C9 components, C3 activator and C3 were isolated in the chamber, the latter complement factor in large concentrations. This further sustained that specific antigen-antibody reactions had occurred in the chamber. One of the 2 patients studied were perfused for 60 h and 40 min. During this period 450 litres of blood were brought into intimate contact with the immunoadsorbent. Proteins in amounts sufficient for immunochemical analysis were isolated within 3 h. IMAGES: |
format | Text |
id | pubmed-2025021 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1975 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-20250212009-09-10 Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients. Langvad, E. Hydén, H. Wolf, H. Kroeigaard, N. Br J Cancer Research Article Circulating serum factors have been said to abrogate the effects of immune response in cancer, i.e. "blocking" and "antigenic inhibition". The aim of this investigation was to isolate such specific factors in a purified and native state. F(ab)2 fragments isolated from hypernephroma were insolubilized on the surfaces of an extracorporeal perfusion chamber which was inserted into the circulation by means of an arterio-venous shunt. As a result, 3 proteins not present in normal serum were isolated and eluted for further study. In immunoelectrophoresis the 3 proteins were specifically precipitated by heterolgous (rabbit) antihypernephroma serum but not by anti-serum directed against normal serum components. Moreover C9 components, C3 activator and C3 were isolated in the chamber, the latter complement factor in large concentrations. This further sustained that specific antigen-antibody reactions had occurred in the chamber. One of the 2 patients studied were perfused for 60 h and 40 min. During this period 450 litres of blood were brought into intimate contact with the immunoadsorbent. Proteins in amounts sufficient for immunochemical analysis were isolated within 3 h. IMAGES: Nature Publishing Group 1975-12 /pmc/articles/PMC2025021/ /pubmed/1220760 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Langvad, E. Hydén, H. Wolf, H. Kroeigaard, N. Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients. |
title | Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients. |
title_full | Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients. |
title_fullStr | Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients. |
title_full_unstemmed | Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients. |
title_short | Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients. |
title_sort | extracorporeal immunoadsorption of circulating specific serum factors in cancer patients. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025021/ https://www.ncbi.nlm.nih.gov/pubmed/1220760 |
work_keys_str_mv | AT langvade extracorporealimmunoadsorptionofcirculatingspecificserumfactorsincancerpatients AT hydenh extracorporealimmunoadsorptionofcirculatingspecificserumfactorsincancerpatients AT wolfh extracorporealimmunoadsorptionofcirculatingspecificserumfactorsincancerpatients AT kroeigaardn extracorporealimmunoadsorptionofcirculatingspecificserumfactorsincancerpatients |